Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human parvoviruses.

L J Anderson1

  • 1Respiratory and Enterovirus Branch, Centers for Disease Control, Atlanta, Georgia 30333.

The Journal of Infectious Diseases
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Human parvovirus B19 infection is usually mild but can be life-threatening for fetuses and immunocompromised individuals. Intravenous immunoglobulin is a potential treatment for chronic B19 infection in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscle mitochondria, function, mass, and quality of life in prostate cancer during androgen deprivation therapy.

Nature communications·2026
Same author

Multiple risk factors in root survivorship: a 4-year study in Concord grape.

The New phytologist·2022
Same author

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Journal of virology·2017
Same author

Whole exome sequence analysis reveals a homozygous mutation in PNPLA2 as the cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease.

International journal of cardiology·2016
Same author

Status Report--Retracing the history of the early development of national chronic disease surveillance in Canada and the major role of the Laboratory Centre for Disease Control (LCDC) from 1972 to 2000.

Health promotion and chronic disease prevention in Canada : research, policy and practice·2015
Same author

Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews.

International journal of cardiology·2014
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026
Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026
Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026
Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Hematology

Background:

  • Human parvovirus B19 (B19) is a widespread virus causing various illnesses.
  • While often benign, B19 infection poses severe risks to fetuses and immunocompromised individuals due to increased red cell production needs or immune deficiencies.

Purpose of the Study:

  • To review the clinical significance of human parvovirus B19 infections.
  • To discuss potential therapeutic strategies, including intravenous immunoglobulin.
  • To highlight recent laboratory advancements impacting B19 disease understanding and management.

Main Methods:

  • Literature review of B19 infection, clinical manifestations, and treatment options.
  • Discussion of diagnostic advancements, including polymerase chain reaction (PCR) assays.

Related Experiment Videos

  • Exploration of new cell culture systems for B19 protein production.

    • Main Results:

    • B19 infection can be severe or fatal in specific patient groups (fetus, immunocompromised).
    • Intravenous immunoglobulin (IVIG) is suggested for chronic B19 in immunodeficient patients and potentially other severe cases.
    • Advanced diagnostics like sensitive PCR assays and new cell lines are improving B19 research.

    Conclusions:

    • B19 infection management requires consideration of patient risk factors.
    • IVIG shows promise in treating severe and chronic B19 infections.
    • Laboratory innovations are expected to accelerate progress in understanding and treating B19-related diseases.